Physiologically Relevant Cell Types with Real-Time Cell Analysis for More Predictive Assays
Continuous real-time cell analysis improves on the laborious end-point assays by providing complete uninterrupted cellular response over the course of your study. Monitor the functional aspects of human induced pluripotent stem cell cardiomyocyte (hiPSC-CM) or primary cardiomyocytes over the entire duration of the experiment for more comprehensive functional evaluation in the context of safety/toxicity assessment, screening of cardiac drugs, or evaluating molecular mechanisms of disease.
|Cardiac Safety Toxicity||Cardiac Drug Discovery||Cardiac Disease Modeling||Cardiomyocyte Maturation||CiPA|
Simplify your workflow. No cell labeling required. Simply seed your cells, monitor, and evaluate the mechanism, efficacy or toxicity response of pharmaceutical drugs in cardiomyocytes
See What Real-Time Cell Analysis Does For You
The xCELLigence CardioECR® system combines real-time impedance monitoring with both multielectrode array (MEA) technology and a pacing function for the evaluation of cardiomyocyte function along with integrated ion channel activity.
|The xCELLigence® RTCA Cardio system uses non-invasive, label-free impedance monitoring to quantitatively evaluate cardiomyocyte health/function in real-time.|
ACEA Biosciences – The Cell Analysis Company
At ACEA Biosciences, our goal is to apply innovative technologies to the analysis of cellular mechanism and response, making studies possible that were not even imaginable just a few years ago. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet our customers’ needs by delivering innovative, flexible, and scalable solutions to advance the next breakthrough in elucidating mechanisms of the human body. ACEA real-time cell analysis and flow cytometry technologies are fueling groundbreaking advancements in life science research and molecular diagnostics.